PX1 Research provides researchers with analytical-grade Cagrilintide accompanied by comprehensive, lot-matched documentation. Every lot undergoes rigorous USA synthesis verification, full-spectrum third-party HPLC/MS and endotoxin (LAL) testing, and same-day dispatch (M–F) from our California and Arizona fulfillment centers to guarantee absolute batch consistency for preclinical investigation.
PX1 Research provides researchers with analytical-grade Cagrilintide accompanied by comprehensive, lot-matched documentation. Every lot undergoes rigorous USA synthesis verification, full-spectrum third-party HPLC/MS and endotoxin (LAL) testing, and same-day dispatch (M–F) from our California and Arizona fulfillment centers to guarantee absolute batch consistency for preclinical investigation.
A certificate of analysis (COA) listing 99% purity for Cagrilintide refers specifically to Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) peak area percentage, not the total weight of peptide in the vial.
HPLC purity measures what percentage of the ultraviolet-absorbing material at 214 nm or 220 nm is the target peptide sequence versus synthesis truncation sequences or related impurities.
Net peptide content, which accounts for counterions like trifluoroacetic acid (TFA) and residual moisture, is a separate measurement that typically reduces actual peptide mass to 80%–90% of the gross lyophilized powder weight.
A complete COA must also confirm chemical identity via mass spectrometry (MS) and safety for cellular or animal models via Limulus Amebocyte Lysate (LAL) endotoxin testing.
Researchers evaluating vendors must demand lot-specific, full-spectrum COAs rather than generic representative reports to ensure rigorous experimental reproducibility.
Cagrilintide is a long-acting, acylated lipopeptide derivative of human amylin currently evaluated in preclinical literature for its role in metabolic signaling, nutrient sensation, and synergistic receptor crosstalk.
In published laboratory research, researchers frequently study the compound—sometimes informally referred to in bench settings as cagri or the cagri peptide—in tandem with incretin mimetics to observe dual-pathway activation in metabolic models.
Because Cagrilintide features a complex primary amino acid sequence coupled with a fatty acid side chain, its chemical synthesis demands precise solid-phase peptide synthesis (SPPS) controls to avoid deletion sequences or incomplete acylation.
To perform reproducible cellular binding assays or receptor activation studies, laboratories must ensure that they order pure Cagrilintide research vials characterized by exact analytical standards rather than unverified commercial grades.
In experimental models comparing multi-receptor metabolic agents, scientists often pair amylin analogs with GLP-1 and GIP receptor agonists available in the PX1 Research catalog, such as Retatrutide research vials and Semaglutide laboratory reagents.
The most common misunderstanding when purchasing research peptides involves conflating RP-HPLC area percentage with net peptide content.
When an analytical laboratory runs RP-HPLC on a sample of Cagrilintide, the detector records optical absorbance over time. The primary peak represents the target molecule, and smaller surrounding peaks represent synthesis impurities. The calculated HPLC purity—for example, 99.2%—indicates that 99.2% of the UV-active peptide material eluted in that run is the intended molecule.
However, HPLC area percentage does not account for non-UV-absorbing components present in the lyophilized cake. Lyophilized peptides naturally contain bound counterions (typically trifluoroacetate from purification solvents) and residual water from freeze-drying.
If a vial containing 10 mg of total lyophilized powder has an HPLC purity of 99% and a net peptide content of 85%, the actual mass of pure Cagrilintide in that vial is 8.5 mg. The remaining 1.5 mg consists of TFA salts and trace moisture. Researchers who calculate molar concentration based on total powder mass without accounting for net peptide content introduce systematic errors into their in vitro protocols.
While HPLC measures chemical purity by separating molecular species, it cannot verify that the dominant peak is actually Cagrilintide. Mass Spectrometry (MS) is required to confirm exact molecular identity.
Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) measures the mass-to-charge ratio (m/z) of the sample. For Cagrilintide, the experimental monoisotopic or average molecular weight measured on the mass spectrum must match the theoretical molecular weight within a strict tolerance window (typically ±1 Da).
A COA that provides HPLC data without an accompanying mass spectrum leaves the structural identity of the peptide unverified. Truncated sequences or isomeric impurities can sometimes co-elute with the target peak on HPLC, but mass spectrometry immediately exposes mass deviations.
To ensure precise experimental design, researchers should verify that the COA provided by their vendor displays a clear mass spectrum showing the expected molecular ion peak corresponding to the exact sequence of the peptide.
During reverse-phase purification, trifluoroacetic acid (TFA) is routinely added to mobile phases as an ion-pairing reagent. Consequently, synthesized peptides naturally yield TFA salts upon freeze-drying.
In sensitive biological assays, residual TFA can exert cytotoxic effects or alter local pH in unbuffered cell cultures. High TFA concentrations can compromise cell viability in primary tissue cultures or cell-based reporter assays.
Furthermore, lyophilized cakes absorb atmospheric moisture during handling and packaging. Standard analytical specifications permit residual water content up to 5%–8% in research-grade peptide preparations.
High-tier synthesis facilities employ moisture determination techniques such as Karl Fischer titration or thermogravimetric analysis alongside counterion quantification. Knowing the precise TFA content and moisture percentage allows researchers to accurately reconstitute 10 mg vials of Cagrilintide to precise working molarities.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are pervasive environmental contaminants that survive standard sterilization techniques.
In cell culture or preclinical animal models, trace endotoxin contamination induces inflammatory cytokine cascades, alters receptor expression, and corrupts experimental baseline measurements. A peptide sample verified at 99% HPLC purity can still harbor dangerous endotoxin levels if purified with contaminated water or handled in non-sterile conditions.
Endotoxin levels are measured using the Limulus Amebocyte Lysate (LAL) assay or recombinant Factor C assay, reported in Endotoxin Units per milligram (EU/mg).
For rigorous preclinical research, peptide reagents should ideally demonstrate endotoxin levels well below 10 EU/mg, with analytical-grade preparations achieving < 0.1 EU/mg to eliminate confounding immune responses in biological assays.
When sourcing reagents, comparing claims on vendor websites can be misleading. Two suppliers claiming '99% purity' may offer fundamentally different materials depending on their quality assurance protocols.
The following matrix outlines the key analytical criteria researchers must evaluate when selecting a supplier:
1. Purity Verification: Low-tier vendors rely on internal or factory-supplied HPLC sheets. Premium suppliers like PX1 Research commission independent, third-party US laboratory testing for every batch.
2. Structural Identity: Low-tier vendors omit mass spectrometry or provide blurry, unreadable scans. Premium suppliers supply high-resolution ESI-MS spectrum data matching theoretical molecular mass.
3. Counterion & Moisture Data: Low-tier vendors ignore TFA salt levels and moisture content. Premium suppliers report net peptide content or quantify TFA/water residuals.
4. Endotoxin Verification: Low-tier vendors do not test for endotoxins. Premium suppliers provide quantitative LAL assay data per lot.
5. Traceability: Low-tier vendors publish one static COA for years across multiple batches. Premium suppliers issue lot-matched COAs linked directly to the physical vial received by the lab.
6. Storage & Dispatch: Low-tier vendors store products at ambient room temperature and ship slowly via uninsulated channels. Premium suppliers maintain temperature-controlled storage and offer immediate same-day dispatch from domestic logistics hubs.
Analyzing analytical reports requires a critical eye. Common red flags indicate that a COA may be fraudulent, outdated, or irremediably generic.
Be cautious if the COA lacks a specific lot or batch number that directly matches the label on the physical vial delivered to your facility.
Watch for cropped or missing chromatogram axes. A legitimate HPLC chromatogram displays clear x-axis run time (minutes) and y-axis absorbance (mAU), allowing you to verify that the run was long enough to separate late-eluting impurities.
Be suspicious of perfectly rounded purity numbers (e.g., '100.0%' or '99.00%') without decimal integration tables detailing individual peak areas and retention times.
Ensure the testing laboratory is an independent, accredited third party rather than an unverified in-house facility operated by the vendor. Cross-referencing testing facility details helps guard against fabricated reports.
To guarantee experimental consistency, procurement officers and principal investigators should establish a routine verification protocol before unboxing reagents.
Step 1: Check the physical vial label for the specific synthesis lot number upon delivery.
Step 2: Access the vendor's documentation portal or contact support to request the lot-matched COA corresponding exactly to that batch number.
Step 3: Verify that the HPLC run conditions specify appropriate mobile phases (e.g., Water/Acetonitrile with 0.1% TFA) and UV detection wavelength (typically 214 nm).
Step 4: Confirm that the MS peak matches the theoretical molecular weight of Cagrilintide.
Step 5: Review the LAL endotoxin result to confirm it falls within safe limits for your planned cell culture or preclinical protocol.
If a supplier cannot or will not provide a lot-specific COA, the material should not be used in quantitative scientific research.
PX1 Research simplifies reagent sourcing by combining uncompromising analytical standards with transparent documentation and rapid domestic fulfillment.
When you purchase verified Cagrilintide from PX1 Research, your order is filled with high-purity, lyophilized peptide packaged in secure, temperature-monitored glass vials to ensure long-term stability.
Every batch is tied to a lot-specific COA containing complete HPLC purity chromatograms, ESI-MS identity spectra, and LAL endotoxin quantification.
Orders placed before 3:00 PM EST (Monday–Friday) ship the same day from our CA and AZ logistics facilities via tracked domestic shipping services, minimizing transit delays.
Our dedicated scientific support team is readily available to answer technical inquiries, assist with lot traceability, or provide full documentation packages prior to purchase.
To secure fully characterized materials for your laboratory, order 10 mg vials of Cagrilintide directly from PX1 Research today.
What does 99% purity mean on a cagrilintide purity COA?
On a Cagrilintide COA, 99% purity indicates that 99% of the UV-absorbing peptide material detected during HPLC analysis corresponds to the target peptide sequence. It measures relative peptide purity compared to synthesis impurities, but does not represent total gross powder mass due to counterions and residual moisture.
What is the difference between HPLC purity and net peptide content?
HPLC purity measures the proportion of target peptide relative to peptide impurities. Net peptide content measures the actual weight percentage of pure peptide within the lyophilized powder, accounting for non-peptide mass such as trifluoroacetate (TFA) salts and residual water, which typically make up 10%–20% of total powder weight.
Why is mass spectrometry necessary alongside HPLC for Cagrilintide?
HPLC separates compounds based on retention time but cannot confirm chemical identity. Mass spectrometry measures the exact molecular weight of the compound, proving that the primary HPLC peak is indeed Cagrilintide and not an isomer or unrelated synthesis byproduct.
What endotoxin levels are acceptable for research-grade Cagrilintide?
For sensitive preclinical and in vitro research, endotoxin levels should be as low as possible, ideally below 10 EU/mg. Premium analytical-grade peptides tested via LAL assay often demonstrate levels under 0.1 EU/mg to prevent confounding inflammatory responses in experimental models.
How can I verify that my Cagrilintide COA is lot-matched?
Compare the lot or batch number printed on the physical vial label directly with the lot number stated on the COA header. If the numbers do not match exactly, or if the vendor provides a single generic COA for all purchases, the documentation is not lot-matched.
How fast does PX1 Research ship Cagrilintide orders?
PX1 Research dispatches orders same-day Monday through Friday when placed before 3:00 PM EST. Orders ship via expedited domestic transit from our California and Arizona logistics hubs with complete tracking information provided upon fulfillment.
Is Cagrilintide supplied by PX1 Research intended for human use?
No. All products supplied by PX1 Research, including Cagrilintide, are strictly manufactured for laboratory research use only in vitro and preclinical research settings. They are explicitly not for human consumption, therapeutic, or diagnostic applications.
Where can I access the COA for my specific batch of Cagrilintide?
You can access lot-specific COAs directly through the PX1 Research online documentation hub or by contacting customer support with your vial's batch number for immediate delivery of HPLC, MS, and endotoxin reports.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.